Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of the 'ACT now & check-it-out' intervention to support patient-initiated follow up for Head and Neck cancer patients.
Matheson L, Greaves C, Duda JL, Wells M, Secher D, Rhodes P, Lorenc A, Jepson M, Ozakinci G, Watson E, Fulton-Lieuw T, Mittal S, Main B, Nankivell P, Mehanna H, Brett J; PETNECK2 research team. Matheson L, et al. Among authors: lorenc a. Patient Educ Couns. 2024 Feb;119:108033. doi: 10.1016/j.pec.2023.108033. Epub 2023 Nov 4. Patient Educ Couns. 2024. PMID: 37988772 Free article.
PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.
Nankivell P, Gaunt P, Gaunt C, Sissons J, Liaskou E, Jefferson Y, Fulton-Lieuw T, Mittal S, Mehanna H; PETNECK2 Research Team. Nankivell P, et al. BMC Cancer. 2024 Jul 10;24(1):823. doi: 10.1186/s12885-024-12470-9. BMC Cancer. 2024. PMID: 38987693 Free PMC article.
Correction: PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.
Nankivell P, Gaunt P, Gaunt C, Sissons J, Liaskou E, Jefferson Y, Fulton-Lieuw T, Mittal S, Mehanna H; PETNECK2 Research Team. Nankivell P, et al. BMC Cancer. 2024 Jul 18;24(1):861. doi: 10.1186/s12885-024-12639-2. BMC Cancer. 2024. PMID: 39026293 Free PMC article. No abstract available.
117 results